As of January 22, 2025, Voyager Therapeutics (VYGR) has a market cap of $0.30 billion USD. According to our data, Voyager Therapeutics is ranked No.6716 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.30 B |
-4.41%
|
Dec 31, 2024 | $0.31 B |
-32.82%
|
Dec 29, 2023 | $0.46 B |
38.36%
|
Dec 30, 2022 | $0.33 B |
125.09%
|
Dec 31, 2021 | $0.15 B |
-62.10%
|
Dec 31, 2020 | $0.39 B |
-48.75%
|
Dec 31, 2019 | $0.76 B |
48.40%
|
Dec 31, 2018 | $0.51 B |
-43.37%
|
Dec 29, 2017 | $0.91 B |
30.30%
|
Dec 30, 2016 | $0.70 B |
-41.83%
|
Dec 31, 2015 | $1.20 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
bluebird bio
BLUE
|
$77.49 M |
-0.000 M
|
USA
|
Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
REGENXBIO
RGNX
|
$0.38 B |
0.000 M
|
USA
|
uniQure
QURE
|
$0.81 B |
0.000 M
|
Netherlands
|
Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
0.000 M
|
USA
|
Adverum Biotechnologies
ADVM
|
$93.20 M |
0.000 M
|
USA
|
Solid Biosciences
SLDB
|
$0.12 B |
-0.000 M
|
USA
|
MeiraGTx
MGTX
|
$0.47 B |
0.000 M
|
USA
|
Rocket Pharmaceuticals
RCKT
|
$1.11 B |
-0.000 M
|
USA
|
Passage Bio
PASG
|
$37.24 M |
0.000 M
|
USA
|
Market Cap | = | VYGR Stock Price | * | VYGR Shares Outstanding |
= | $5.42 | * | 54.63 M | |
= | $0.30 B |